JP2023553253A5 - - Google Patents
Info
- Publication number
- JP2023553253A5 JP2023553253A5 JP2023526173A JP2023526173A JP2023553253A5 JP 2023553253 A5 JP2023553253 A5 JP 2023553253A5 JP 2023526173 A JP2023526173 A JP 2023526173A JP 2023526173 A JP2023526173 A JP 2023526173A JP 2023553253 A5 JP2023553253 A5 JP 2023553253A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- period
- composition according
- day
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063106790P | 2020-10-28 | 2020-10-28 | |
| US63/106,790 | 2020-10-28 | ||
| US202163155637P | 2021-03-02 | 2021-03-02 | |
| US63/155,637 | 2021-03-02 | ||
| PCT/US2021/057123 WO2022094133A1 (en) | 2020-10-28 | 2021-10-28 | Regimens for the treatment of hair loss disorders with deuterated jak inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553253A JP2023553253A (ja) | 2023-12-21 |
| JP2023553253A5 true JP2023553253A5 (cg-RX-API-DMAC7.html) | 2024-11-01 |
Family
ID=78725692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526173A Pending JP2023553253A (ja) | 2020-10-28 | 2021-10-28 | 重水素化jak阻害剤による脱毛障害の治療のためのレジメン |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023215520A1 (en) * | 2022-05-04 | 2023-11-09 | Sun Pharmaceutical Industries, Inc. | Dosage regimens for treatment with deuterated jak inhibitors |
| US12364699B2 (en) * | 2023-10-10 | 2025-07-22 | Sun Pharmaceuticals Industries, Inc. | Method of treating hair loss disorders |
| US12247034B1 (en) * | 2024-04-19 | 2025-03-11 | Sun Pharmaceutical Industries, Inc. | Crystalline form of deuruxolitinib phosphate |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9925962D0 (en) | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| CZ20033211A3 (cs) | 2001-05-03 | 2004-09-15 | F. Hoffmann-La Roche Ag | Farmaceutická léková forma amorfního nelfinavir mesylátu |
| WO2006039237A1 (en) | 2004-09-29 | 2006-04-13 | Cordis Corporation | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
| WO2010083283A2 (en) | 2009-01-15 | 2010-07-22 | Incyte Corporation | Processes for preparing jak inhibitors and related intermediate compounds |
| EP3450434B1 (en) | 2012-06-15 | 2021-02-24 | CoNCERT Pharmaceuticals, Inc. | Deuterated derivatives of ruxolitinib |
| US10561659B2 (en) | 2016-05-04 | 2020-02-18 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated JAK inhibitors |
| EP3921318A1 (en) | 2019-02-06 | 2021-12-15 | Concert Pharmaceuticals Inc. | Process for preparing enantiomerically enriched jak inhibitors |
| WO2023018904A1 (en) * | 2021-08-11 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
| US12364699B2 (en) * | 2023-10-10 | 2025-07-22 | Sun Pharmaceuticals Industries, Inc. | Method of treating hair loss disorders |
-
2021
- 2021-10-28 US US18/033,730 patent/US20230390292A1/en active Pending
- 2021-10-28 JP JP2023526173A patent/JP2023553253A/ja active Pending
- 2021-10-28 PE PE2023001507A patent/PE20231945A1/es unknown
- 2021-10-28 MX MX2023005027A patent/MX2023005027A/es unknown
- 2021-10-28 AU AU2021372512A patent/AU2021372512A1/en active Pending
- 2021-10-28 KR KR1020237017998A patent/KR20230093504A/ko active Pending
- 2021-10-28 CA CA3196551A patent/CA3196551A1/en active Pending
- 2021-10-28 IL IL302401A patent/IL302401A/en unknown
- 2021-10-28 WO PCT/US2021/057123 patent/WO2022094133A1/en not_active Ceased
- 2021-10-28 EP EP21811647.3A patent/EP4236956A1/en active Pending
-
2023
- 2023-04-26 CL CL2023001201A patent/CL2023001201A1/es unknown
- 2023-04-27 JO JOJO/P/2023/0090A patent/JOP20230090A1/ar unknown
- 2023-04-28 DO DO2023000085A patent/DOP2023000085A/es unknown
- 2023-05-25 CO CONC2023/0006808A patent/CO2023006808A2/es unknown